NCT06750185 - Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 13, 2025

Primary Completion Date

June 30, 2028

Study Completion Date

June 30, 2028

Conditions

Advanced Solid Tumor

Interventions

BIOLOGICAL

BNT317 DL1

Intravenous infusion

BIOLOGICAL

BNT317 DL2

Intravenous infusion

BIOLOGICAL

BNT317 DL3

Intravenous infusion

BIOLOGICAL

BNT317 DL4

Intravenous infusion

BIOLOGICAL

BNT317 DL5 (intermediate)

Intravenous infusion

BIOLOGICAL

BNT317 DL6 (intermediate)

Intravenous infusion

BIOLOGICAL

BNT317 DL7 (additional)

Intravenous infusion

Trial Locations (9)

2031

RECRUITING

Scientia Clinical Research, Randwick

3168

RECRUITING

Monash Medical Centre Clayton, Clayton

4215

RECRUITING

Tasman Oncology Research Ltd, Southport

28078

RECRUITING

Carolina BioOncology Institute, LLC, Huntersville

40202

RECRUITING

Norton Cancer Institute PARENT, Louisville

49546

RECRUITING

START Midwest, Grand Rapids

75230

RECRUITING

Mary Crowley Cancer Research, Dallas

78229

RECRUITING

South Texas Accelerated Research Therapeutics (START), LLC, San Antonio

02903

RECRUITING

Rhode Island Hospital, East Providence